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. Nongenomic actions of steroids were reported earlier in myometrium (34) . However, whether or not GPER is involved in myometrial functions remains to be clarified. The present study was undertaken to investigate the effects of GPER activation on membrane potential, cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) and contractility on rat myometrium, using the selective GPER agonist G-1 (4) and antagonist G-15 (14) .
MATERIALS AND METHODS

Primary Culture of Myometrial Cells
Primary myometrial cells were prepared from rat uterus according to the procedure described by Krizsan-Agbas et al. (26) with some modifications (13) . Animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee. Adult (nonpregnant) female Sprague-Dawley rats (Ace Animals, Boyertown, PA) were anesthetized with urethane (1.2 g/kg ip); uterine horns were immediately excised and immersed in cold Hanks balanced salt solution (HBSS). The myometrium was rapidly separated from endometrium and stroma and then minced into fragments (about 1 mm 3 ). Tissues were digested for 1.5 h at 37°C by collagenase type II (600 U/ml, Sigma-Aldrich, St. Louis, MO) in DMEM/F12 culture medium, followed by trituration with a sterile Pasteur pipette and filtration through a cell strainer with 70-m pores. After collection, the cells were washed twice by centrifugation (1,000 RPM, 10 min) and resuspended in fresh DMEM/F12 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin and then plated on collagen-coated coverslips. Cultures were maintained at 37°C in a humidified atmosphere with 5% CO 2; the medium was changed every 2-3 days. Myometrial cells were used for calcium imaging experiments after 3-5 days in culture.
Reverse Transcriptase-Polymerase Chain Reaction
Total RNA from rat myometrium was isolated using TRIzol reagent according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). The purity and concentration of RNA were assessed by spectrophotometrical analysis. First-strand cDNA was synthesized from 3 g of total RNA with random hexamer primers and the SuperScript III reverse transcriptase according to the manufacturer's protocol (Invitrogen). Three microliters of 20 l cDNA product were amplified with the following specific primers based on GPER (NM_133573) and ␤-actin (NM_031144) sequences: GPER: 5=-TCTGTGAC-CCTTTCAGCAAGTCCT-3= (upstream), 5=-AGAAGGCTGCCAG-GTTGACTATGT-3= (downstream); ␤-actin: 5=-CCATTGAACACG-GCATTGTCACCA-3= (upstream), 5=-ACTCCTGCTTGCTGATC-CACATCT-3= (downstream). Amplifications were performed using Platinum Taq DNA polymerase (Invitrogen) as follows. GPER: 38 cycles of 94°C for 60 s, 58°C for 60 s, and 72°C for 60 s; ␤-actin: 30 cycles of 94°C for 30 s, 55°C for 45 s, and 72°C for 60 s. The polymerase chain reaction products (987 bp and 876 bp, respectively) were visualized by an ethidium bromide staining under UV light following electrophoresis on 1% agarose gel.
Immunocytochemistry
Myometrial cells on coverslips were fixed in 4% paraformaldehyde for 20 min. After being blocked with normal donkey serum (1:50 in PBS, 0.5% BSA, 0.4% Triton X-100), the cells were incubated with GPER/GPR30 antibody (1:200 dilution) as previously described (5) . GPER antibody was a rabbit polyclonal antibody directed against the human COOH-terminus (MBL International, Woburn, MA). For control experiments, the antibody was incubated with a 10ϫ excess of peptide at 4°C overnight. After several washes with PBS, cells were incubated with rabbit IgG Texas Red (1:30, Vector Laboratories, Burlingame, CA). The cell nuclei were stained by mounting with DAPI-Fluoromount-G (Southern Biotech, Birmingham, AL). Sections were examined under a confocal scanning laser microscope (Leica TCS SL) with excitation wavelengths set to 405 nm for DAPI and 561 nm for Texas Red, in the sequential mode.
Optical Imaging Using DiBAC 4(3)
Bis-oxonol (bis-[1,3-dibutylbarbituric acid] trimethineoxonol) [DiBAC4(3)], a slow-response voltage-sensitive fluorescent dye, has been successfully used to assess relative changes in membrane potential of single cells (15) . The method was similar to that previously described (8, 9) . Briefly, myometrial cells were incubated for 30 min in HBSS containing 0.5 mM DiBAC 4(3). The fluorescence (excitation wavelength ϭ 480 nm, emission wavelength ϭ 540 nm) was continuously recorded at a rate of 10 points/min. Background values (windows of identical area placed beside the cells) were subtracted. The dye partition between the cell membrane and the cytosol is a function of membrane potential. Depolarization of the membrane leads to a sequestration of the dye into cytosol and is associated with an increase in fluorescence intensity; whereas the dye concentrates in the cell membrane during hyperpolarization, leading to a decrease of fluorescence intensity in cytosol (11) . Calibration of DiBAC 4(3) fluorescence was performed using the Na ϩ -K ϩ ionophore gramicidin in Na ϩ -free physiological solution (11) . In experiments with ionic substitution, Na ϩ was replaced with N-methyl-D-glucamine.
Calcium Imaging
Intracellular Ca 2ϩ measurements were performed as previously described (5, 7, 10, 13) . Briefly, cells were incubated with 5 M fura-2 AM (Invitrogen) in HBSS at room temperature for 45 min, in the dark, washed three times with dye-free buffer, and then incubated for another 45 min to allow for complete deesterification of the dye. Coverslips were subsequently mounted in a custom-designed bath on the stage of an Eclipse TE 2000-U Nikon microscope equipped with a Roper Scientific CCD camera (Optical Apparatus, Ardmore, PA) or on a stage of a Nikon Eclipse TiE microscope equipped with a Perfect Focus System and a Photometrics CoolSnap HQ2 CCD camera (Optical Apparatus). Fura-2 AM fluorescence (emission ϭ 510 nm), following alternate excitation at 340 and 380 nm, was acquired at a frequency of 0.33 Hz from regions of interest located on cytoplasm. Data were acquired and analyzed using a Metafluor or NIS-Elements AR 3.1 software (Optical Apparatus). The ratio of the fluorescence signals (340/380 nm) was converted to Ca 2ϩ concentrations (21) . In Ca 2ϩ -free experiments, CaCl2 was omitted and 2.5 mM EGTA was added.
Intracellular Microinjection Of Uterine Smooth Muscle Cells
Injections were performed using Femtotips II, InjectMan NI2, and FemtoJet systems (Eppendorf) as previously reported (7, 10, 13) . Pipettes were back filled with an intracellular solution composed of 110 mM KCl, 10 mM NaCl, and 20 mM HEPES (pH 7.2) (22) with or without G-1. The injection time was 0.4 s at 60 hPa with a compensation pressure of 20 hPa to maintain the microinjected volume to Ͻ1% of cell volume, as measured by microinjection of a fluorescent compound (Fura-2 free acid) (22) . The intracellular concentration of G-1 was determined based on the G-1 concentration in the pipette and the volume of injection.
Tissue Preparation and Tension Measurement
Uterine strips were prepared from nonpregnant Sprague-Dawley female rats according to the procedures described by Shintani et al. (42) . The middle part of the uterine horn was excised in a longitudinal direction and cut into strips measuring 2 mm in width and 5 mm in length. All measurements were performed at 37°C, in Krebs solution with the following composition (in mM): 127 NaCl, 1.9 KCl, 1.2 KH 2PO4, 2.4 CaCl2, 1.3 MgCl2, 26 NaHCO3, and 5 glucose, saturated with 95% O2-5% CO2.
The uterine strips were mounted vertically in a 5-ml organ bath using a force transducer (ML T0201/RAD; ADInstruments, Colorado Springs, CO) coupled to a Quad Bridge Amplifier (ADInstruments).
Contractions were recorded using a PowerLab system and Chart 5 software (ADInstruments). The resting load was adjusted to ϳ0.5 g to obtain a maximal response to 40 mM K ϩ . The contractile response was analyzed by using three parameters: 1) area under the contractility curve was determined as the integrated force from the start of the induced contraction up to 10 min following the application of the compound; 2) frequency of myometrial contractions was determined as the number of contractions occurring during a 10-min period before and after the application of the compound; and 3) amplitude of myometrial contractions was defined as the distance between the peak and the initial baseline of the contractions in a period of 10 min before and after the application of the compound.
Statistical Analysis
One-way ANOVA or two-way ANOVA were used; a P value of Ͻ0.05 was considered statistically significant.
RESULTS
GPER Expression and Immunoreactivity in Rat Myometrium
GPER mRNA was identified using reverse transcriptase-polymerase chain reaction assay as a 987 bp product in rat myometrium; ␤-actin (876 bp) was the internal control (Fig. 1A) . Using immunocytochemical method and a GPER-specific antibody, GPER was detected in myometrial cells as red immunofluorescence in the cytosol (Fig. 1, B-D) . Very weak or no immunoreactivity was present in cells incubated with the GPER antibody preabsorbed with the GPER blocking peptide, supporting the specificity of the immunostaining (Fig. 1, E-G) .
G-1 Depolarizes Myometrial Cells
The resting membrane potential of rat myometrial cells, monitored by the voltage-sensitive dye DiBAC 4 (3), was Ϫ51 Ϯ 1.8 mV (n ϭ 74). This value is similar to that measured from uterine strips by classical electrophysiological techniques (27) . Extracellular administration of G-1 (5 ϫ 10 Ϫ8 M, 5 ϫ 10 Ϫ7 M, and 5 ϫ 10 Ϫ6 M) induced a concentration-dependent membrane depolarization with a mean amplitude of 3.2 Ϯ 0.9 (n ϭ 12), 14.6 Ϯ 1.3 (n ϭ 19), and 19.2 Ϯ 1.7 mV (n ϭ 7), respectively (Fig. 2) . The depolarization induced by G-1 (5 ϫ 10 Ϫ7 M) was prevented by pretreatment with G-15 (5 ϫ 10 Ϫ6 M, 15 min) (n ϭ 14) (Fig. 2) . G-1-induced depolarization was abolished when the cells were incubated in a Na ϩ -free solution (n ϭ 16), indicating the involvement of Na ϩ influx in G-1-induced myometrial depolarization (Fig. 2) . (Fig. 3, A and E) . G-1-induced increase in [Ca 2ϩ ] i occurred slowly, starting 1-2 min after administration of G-1, and reached a plateau after 6 -7 min; a representative example is shown in Fig. 3A . The increase in [Ca 2ϩ ] i produced by G-1 (5 ϫ 10 Ϫ7 M) was largely abolished (59 Ϯ 4 nM) by pretreatment with G-15 (5 ϫ 10 Ϫ6 M, 15 min), a GPER antagonist (10) (Fig. 3, A and E) . In the presence of nifedipine, a L-type Ca 2ϩ channel blocker (10 Ϫ6 M, 10 min pretreatment), application of G-1 (5 ϫ 10 Ϫ7 M) increased [Ca 2ϩ ] i only by 152 Ϯ 2.6 nM (n ϭ 18 cells) (Fig. 3, B and E) . The effect was significantly reduced compared with G-1 alone (P Ͻ 0.5), indicating the involvement of Ca 2ϩ entry through plasmalemmal Ca 2ϩ channels. Indeed, in Ca 2ϩ -free saline, administration of G-1 (5 ϫ 10 Ϫ7 M) elevates [Ca 2ϩ ] i only by 74 Ϯ 0.9 nM (n ϭ 11 cells) (Fig. 3,  C and E) . Similarly, in Na ϩ -free saline, G-1 (5 ϫ 10 Ϫ7 M) increases [Ca 2ϩ ] i only by 81 Ϯ 3 nM (n ϭ 15 cells) (Fig. 3, D and E) . We also assessed the participation of store-operated calcium entry (SOCE) in the response to G-1. Addition of 2 mM Ca (Fig. 4) .
GPER Activation Increases [Ca
Intracellular microinjection of G-1 elevates [Ca 2ϩ ] i . Intracellular microinjection of control buffer induced a small elevation in [Ca
2ϩ ] i with a mean amplitude of 72 Ϯ 1.6 nM in rat myometrial cells (n ϭ 10 cells) (Fig. 5, A, F, and G) . Microinjection of G-1 (5 ϫ 10 Ϫ7 M final concentration inside the cell) produced a robust and transitory increase in [Ca 2ϩ ] i by 983 Ϯ 8 nM (n ϭ 10 cells) (Fig. 5, B, F, and G) . The effect occurred faster and had a higher amplitude than that induced by extracellular application (seconds vs. minutes) (P Ͻ 0.05) (for comparison see Fig. 5F and Fig. 3A) . Pretreatment with G-15 (5 ϫ 10 Ϫ6 M, 15 min) prevented the effects of intracellularly injected G-1 (Fig. 5, C, F, and G) (n ϭ 11 cells) ; the small increase in [Ca 2ϩ ] i produced by G-1 administration in the presence of the antagonist was not significantly different from that in control injection. Pretreatment with nifedipine (10 Ϫ6 M, 10 min) markedly reduced the G-1-induced increase in [Ca 2ϩ ] i to 102 Ϯ 8 nM (Fig. 5, D, F, and G) (n ϭ 8 cells) . When G-1 (5 ϫ 10 Ϫ5 M in the pipette) was applied extracellularly by Femtotips, in the close vicinity (1-2 m) of the cell membrane induced a slow increase in [Ca 2ϩ ] i by 103 ϩ 2.6 nM with a plateau at 5-8 min after administration (n ϭ 6 cells) (Fig. 5, E,  H, and I) .
G-1 Increases Uterine Strips Contractility
In basal conditions, the contractility of rat uterine strips was characterized by the following parameters: 1) the area under the contractility curve was 96 Ϯ 3.2 g/10 min, 2) the frequency of myometrial contractions was 5.4 Ϯ 0.8 contractions/10 min, and 3) the amplitude of myometrial contractions was 1.06 ϩ 0.09 g. Administration of G-1 (5 ϫ 10 Ϫ7 M) increased the area under the contractility curve by 862 Ϯ 4.1%, the frequency of myometrial contractions by 426 Ϯ 3.4% and the amplitude of contractions by 52 Ϯ 0.7% (n ϭ 6 experiments) compared with basal conditions. In addition, a transitory increase in basal tone was also observed. A representative trace is shown in Fig. 6A . Pretreatment of the uterine strips with G-15 (5 ϫ 10 Ϫ6 M, 10 min) or nifedipine (10 Ϫ6 M) abolished the effect of G-1 on contractility (Fig. 6, B and C) . In addition, nifedipine also abolished the basal contractions (Fig. 6C) .
DISCUSSION
GPER has been identified in several tissues including uterus (25, 31) . Recent evidence indicate that the receptor is involved in endometrial pathology (24, 43, 45, 46) , while the role of GPER in myometrium is largely unexplored. Recently, GPER has been proposed to act as a negative regulator of ER␣-dependent uterine growth in response to estradiol (20) . However, GPER-deficient mice did not seem to have an impaired uterine function (32) . In this study, we examined the role of GPER in nonpregnant rat myometrium, by assessing the effect of selective GPER ligands, previously characterized (4, 14) , on [Ca 2ϩ ] i , membrane potential, and uterine contractility. First, we detected the presence of GPER expression in nonpregnant rat myometrium using reverse transcriptase-polymerase chain reaction and immunocytochemistry. GPER immunoreactivity was identified intracellularly, as reported in several other cell types (12, 33, 39) . Next, using a slowresponse voltage-sensitive dye, we found that administration of G-1, a GPER-selective agonist (4), produced a concentrationdependent depolarization of rat myometrial cells. G-1-induced depolarization was abolished in a Na ϩ -free saline, indicating the involvement of Na ϩ influx in the response. In myometrial cells, Na ϩ influx occurs trough voltage-gated Na ϩ channels and nonselective cation channels from transient receptor potential channels family (TRPC). All TRPCs except for TRPC3 are expressed in nonpregnant rat myometrium (3), while the human myometrium lacks TRPC2 (50) . The specific Na 2ϩ influx pathway(s) associated with GPER activation remains to be clarified.
In myometrium, similar to other excitable tissues, depolarization due to various stimuli leads to an opening of plasmalemmal voltage-sensitive Ca 2ϩ channels, followed by an increase in cytoplasmatic Ca 2ϩ concentration and contraction (49) . With respect to the concentrations of GPER ligands used, notable differences were reported in different cellular systems and between endogenously expressing and GPER-transfected cells. Several recent publications, including ours (2, 5, 28) , indicate that in primary cells, G-1 activates GPER in micromolar range. In transfected cells, which overexpress the receptor, lower concentrations of agonists may be sufficient to activate the receptor (4 -free saline, the response to G-1 was markedly reduced, indicating a limited or lack of participation of sarcoplasmic reticulum. SOCE is an important Ca 2ϩ influx pathway in many nonexcitable and some excitable cells (36) . We examined an eventual participation of SOCE in the response to G-1. Depletion of the internal Ca 2ϩ stores by treatment with thapsigargin, an inhibitor of sarcoplasmic-endoplasmic reticulum Ca 2ϩ -ATPase, evoked a robust SOCE, which was not affected by treatment with nifedipine. G-1-induced [Ca 2ϩ ] i response was similar to the constitutive Ca 2ϩ entry and did not seem to involve a SOCE mechanism. Previously, we reported that GPER activation by G-1 produced an increase in [Ca 2ϩ ] i in neurons (5) and breast cancer cells (2) . Similarly, other reports indicate that GPER activation enhanced [Ca 2ϩ ] i in cells endogenously expressing or transfected with the receptor (4, 35 ,39 ). GPCR are active structural proteins located usually in the cell membrane. However, increasing evidence indicates that angiotensin II receptors are active not only when stimulated from outside but also from inside the cells (6, 37, 38) . We recently reported that intracellular angiotensin II activates myometrial cells via an intracrine mechanism (13) . Also, we characterized the intracellular activation of cannabinoid CB 1 receptors by anandamide (10) . With respect to GPER, the subcellular localization has yet to be firmly established; both intracellular and plasma membrane localizations have been reported (16, 33, 39, 41) . Initially, GPER was shown to be uniquely localized to the endoplasmic reticulum in cells transiently or constitutively expressing GPER (39) . In contrast, other studies using morphological and functional assays showed that GPER is expressed only in the plasma membrane of GPER-transfected cells (16, 29, 44) or of CA2 pyramidal neurons of the rat hippocampus (19) . In myometrial cells, G-1 administered intracellularly by microinjection produced a faster and transitory increase in [Ca 2ϩ ] i , with a higher amplitude than that induced by extracellular administration of G-1 in the same final concentration. Since G-1 is a membrane permeant compound, we also applied G-1 on the extracellular side of the membrane by microinjection, using Femtotips. In this case, we noted a small and delayed increase in [Ca 2ϩ ] i , whose shape and kinetics were similar to that produced by bath application of G-1. We attribute the differences in kinetics and amplitude of responses to intracellular versus extracellular administration of the agonist to the location of GPER in myometrial cells. Our calcium imaging and immunocytochemistry results support an intracellular location of functional GPER. This is in agreement with a recent report which found that GPER is localized intracellularly in other tissues (12) . The response was abolished by pretreatment with G-15, a GPER antagonist, indicating that this response is receptor specific.
Increase of [Ca 2ϩ ] i and stimulation of myosin light chain kinase (MLCK) via Ca 2ϩ -calmodulin is essential for myometrial contraction. To identify the effect of GPER activation on uterine contraction, the next series of experiments were carried out on rat uterine strips. Administration of G-1 caused a robust stimulant effect on uterine strip contractility by increasing the frequency and amplitude of uterine contractions. Similarly, estrogen has been reported to stimulate uterine contractility in perfused nonpregnant human or swine uterus (30, 40) or in artificially inseminated sows (48) . Taken together, our results support the involvement of GPER activation in myometrial depolarization and contraction. Similarly, a very recent report, published when the present study was under review, indicates that GPER activation is associated with increased contractility of the human myometrium and the receptor is most likely to be involved in myometrium physiology during pregnancy (28) .
